Lv41
640 积分 2021-07-08 加入
Validation of Liquid Biopsy Using a Methylated SEPT9 Assay and Integrated Index for Detecting Hepatocellular Carcinoma
3小时前
已完结
Integrating cell-free DNA methylation of SEPT9 and SFRP2 into a machine learning model for early diagnosis of HCC
4小时前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
5天前
已完结
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
2个月前
已完结
The CD58–CD2 axis in cancer immune evasion
4个月前
已完结
Genome‐wide identification of age‐related CpG sites for age estimation from blood DNA of Han Chinese individuals
6个月前
已完结
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
7个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
8个月前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
8个月前
已完结
From geroscience to precision geromedicine: Understanding and managing aging
8个月前
已完结
皖公网安备34019202002308
